| Drug Name |
Metoclopramide hydrochloride |
| Drug ID |
BADD_D01443 |
| Description |
Diabetic gastroparesis is a condition that causes frequent nausea and vomiting, which has a negative impact on quality of life and poses a significant burden on the healthcare system.[A184934] Metoclopramide is a dopamine antagonist used to treat nausea and vomiting that may be associated with diabetic gastroparesis in addition to gastroesophageal reflux disease (GERD). It can also be used to prevent nausea or vomiting associated with chemotherapy or certain surgical or diagnostic procedures.[L8417]
One unique property of this drug is that it does not increase gastric acid secretion. It is available in the oral tablet form or in solution, and can also be administered through the intravenous route.[T683] Metoclopramide was initially approved by the FDA in 1980.[A184922] |
| Indications and Usage |
Metoclopramide in the oral tablet form is used for symptomatic treatment of both acute and recurrent diabetic gastroparesis, in addition to the treatment of gastroesophageal reflux disease (GERD) in patients who have failed to respond to traditional therapy.[L8414] A nasal spray formulation is also indicated to treat adults with acute, recurrent diabetic gastroparesis.[L14381]
In the intravenous injection form, it is indicated for the above conditions as well as for the prevention of vomiting that may follow emetogenic chemotherapy or nausea and vomiting after surgery. Intravenous metoclopramide facilitates intubation of the small bowel and stimulates gastric emptying and barium flow in patients who require radiological examination of the stomach or small intestine. In some cases, the delay of gastrointestinal emptying interferes with the radiographic visualization of the gastrointestinal tract, and metoclopramide is used to facilitate emptying in these cases, allowing for adequate diagnostic visualization.[L8417]
Some off-label uses of metoclopramide include the management of radiation-induced nausea and vomiting, gastric bezoars, intractable hiccups, and migraine pain.[A184961,A184964,A184967,A40105] |
| Marketing Status |
approved; investigational |
| ATC Code |
A03FA01 |
| DrugBank ID |
DB01233
|
| KEGG ID |
D02213; D05008
|
| MeSH ID |
D008787
|
| PubChem ID |
23659
|
| TTD Drug ID |
D08VYV
|
| NDC Product Code |
51927-0185; 55154-0450; 62559-166; 72089-307; 76045-101; 76420-295; 43386-580; 71872-7265; 0404-9910; 49452-4715; 0121-0576; 62559-165; 76003-0739; 43386-581; 62135-526; 0121-1576; 55154-2353; 51604-0005; 57451-1119; 57451-1139; 66689-031; 51552-1549; 45562-1737; 23155-240; 76045-213; 40700-0010 |
| UNII |
W1792A2RVD
|
| Synonyms |
Metoclopramide | 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide | Metaclopramide | Maxolon | Rimetin | Metoclopramide Hydrochloride | Hydrochloride, Metoclopramide | Metoclopramide Monohydrochloride | Monohydrochloride, Metoclopramide | Metoclopramide Monohydrochloride, Monohydrate | Primperan | Reglan | Cerucal | Metoclopramide Dihydrochloride | Dihydrochloride, Metoclopramide |
